Loading...
Please wait, while we are loading the content...
Similar Documents
Expression Levels of Estrogen Receptor-α, Estrogen Receptor-β, Coactivators, and Corepressors in Breast Cancer
| Content Provider | Semantic Scholar |
|---|---|
| Author | Kurebayashi, Junichi Otsuki, Takemi Kunisue, Hironori Tanaka, Katsuhiko Yamamoto, Shigeru Sonoo, Hiroshi |
| Copyright Year | 2000 |
| Abstract | Recent studies have indicated that a complex machinery of transactivation of target genes by estrogen or antiestrogen through estrogen receptor (ER) exists. However, the substantial roles of ER-β, coactivators, and corepressors in the development and progression of breast cancer remain to be elucidated. To obtain some clue to these roles, we screened the expression levels of ER-α, ER-β, coactivators (SRC-1, TIF2, AIB1, CBP, and P/CAF) and corepressors (N-CoR and SMRT) in 6 normal mammary glands, 6 intraductal carcinomas, 22 invasive ductal carcinomas, and 7 breast cancer cell lines using a multiplex reverse transcription-PCR. ER-α mRNA expression levels significantly correlated with ER-α protein levels measured by enzyme immunoassay in the breast cancer tissues and cell lines. A significant correlation of expression levels was observed between ER-α and TIF2, AIB1, P/CAF, and N-CoR, and between ER-β and AIB1 and CBP in the tissue samples. A significant correlation was also observed between ER-α and ER-β and between ER-β and CBP in the cell lines. The expression levels of ER-α, TIF2, and CBP were significantly higher in the intraductal carcinomas than those in the normal mammary glands. In addition, the expression levels of ER-α and N-CoR were significantly higher in the intraductal carcinomas than those in the invasive ductal carcinomas. These findings suggest a positive correlation of expression levels among ER-α and cofactors and among ER-β and cofactors, an up-regulation of expression levels of ER-α and cofactors during the development of intraductal carcinomas from normal mammary glands, and a decrease in their expression levels during the progression of breast cancer. |
| Starting Page | 512 |
| Ending Page | 518 |
| Page Count | 7 |
| File Format | PDF HTM / HTML |
| Volume Number | 6 |
| Alternate Webpage(s) | http://clincancerres.aacrjournals.org/content/clincanres/6/2/512.full.pdf |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |